Back to RecallTracker
Health Canada Health products

Maximum Strength Acid Reducer Without prescription: NDMA impurity

Issued March 11, 2022
Issue
Presence of N-nitrosodimethylamine (NDMA) close or above the acceptable concentration limit in affected lots.
Hazard description
Product quality
What to do
Talk to your doctor or pharmacist at your earliest convenience about alternative, non-ranitidine treatment options appropriate for your health circumstances. There are many prescription and over-the-counter drug alternatives in Canada that are authorized for the same or similar uses as ranitidine. Individuals taking a prescription ranitidine drug, including a recalled product, should not stop taking it unless they have spoken to their health care provider and obtained alternative treatment, as the risk of not treating the condition may be greater than the risk related to NDMA exposure. Contact your health care provider if you have taken a ranitidine product and you have concerns about your health. Report any health product adverse events or complaints to Health Canada.
Product
Product name
Maximum Strength Acid Reducer Without prescription
Reference
ID
RA-63977